ENPP1 Antikörper (AA 1-75) (HRP)

Produktnummer ABIN7151388

Produktdetails anti-ENPP1 Antikörper (HRP)

Target: ENPP1 (Ectonucleotide Pyrophosphatase/phosphodiesterase 1 (ENPP1))

Bindungsspezifität: AA 1-75

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ENPP1 Antikörper ist konjugiert mit HRP

Applikation: ELISA

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 protein (1-75AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu ENPP1

Target: ENPP1 (Ectonucleotide Pyrophosphatase/phosphodiesterase 1 (ENPP1))

Andere Bezeichnung: ENPP1 (ENPP1 Produkte)

Synonyme: ENPP1 antikoerper, si:ch211-142e24.2 antikoerper, zgc:136238 antikoerper, ARHR2 antikoerper, M6S1 antikoerper, NPP1 antikoerper, NPPS antikoerper, PC-1 antikoerper, PCA1 antikoerper, PDNP1 antikoerper, 4833416E15Rik antikoerper, AI428932 antikoerper, C76301 antikoerper, CD203c antikoerper, E-NPP1 antikoerper, Ly-41 antikoerper, Npps antikoerper, Pca antikoerper, Pca-1 antikoerper, Pdnp1 antikoerper, ttw antikoerper, twy antikoerper, Pc1 antikoerper, ectonucleotide pyrophosphatase/phosphodiesterase 1 antikoerper, ectonucleotide pyrophosphatase/phosphodiesterase 1 L homeolog antikoerper, ENPP1 antikoerper, enpp1 antikoerper, enpp1.L antikoerper, Enpp1 antikoerper

Hintergrund:

Background: By generating PPi, plays a role in regulating pyrophosphate levels, and functions in bone mineralization and soft tissue calcification. PPi inhibits mineralization by binding to nascent hydroxyapatite (HA) crystals, thereby preventing further growth of these crystals. Preferentially hydrolyzes ATP, but can also hydrolyze other nucleoside 5\' triphosphates such as GTP, CTP, TTP and UTP to their corresponding monophosphates with release of pyrophosphate and diadenosine polyphosphates, and also 3\',5\'-cAMP to AMP. May also be involved in the regulation of the availability of nucleotide sugars in the endoplasmic reticulum and Golgi, and the regulation of purinergic signaling. Appears to modulate insulin sensitivity and function.

Aliases: Alkaline phosphodiesterase 1 antibody, ARHR2 antibody, COLED antibody, E-NPP 1 antibody, Ectonucleotide pyrophosphatase/phosphodiesterase 1 antibody, Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 antibody, ENPP1 antibody, ENPP1_HUMAN antibody, Ly 41 antigen antibody, M6S1 antibody, Membrane component chromosome 6 surface marker 1 antibody, NPP1 antibody, NPPase antibody, NPPS antibody, Nucleotide pyrophosphatase antibody, PC 1 antibody, PC-1 antibody, PCA1 antibody, PDNP1 antibody, Phosphodiesterase I/nucleotide pyrophosphatase 1 antibody, Plasma cell membrane glycoprotein 1 antibody, Plasma-cell membrane glycoprotein PC-1 antibody

UniProt: P22413

Pathways: Regulation of Carbohydrate Metabolic Process